Cargando…

Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015

Major β-thalassemia (β-TM) is one of the most common inherited hemolytic types of anemia which is caused as a result of absent or reduced synthesis of β-globin chains of hemoglobin. This defect results in red blood cells lysis and chronic anemia that can be treated by multiple blood transfusions and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darvishi Khezri, Hadi, Salehifar, Ebrahim, Kosaryan, Mehrnoush, Aliasgharian, Aily, Jalali, Hossein, Hadian Amree, Arash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779508/ https://www.ncbi.nlm.nih.gov/pubmed/26997953 http://dx.doi.org/10.1155/2016/3046373

Ejemplares similares

Silymarin therapy and improvement of cardiac outcome in patients with β-thalassemia major
por: Khezri, Hadi Darvishi, et al.
Publicado: (2016)

Treatment Status of Patients with B-Thalassemia Major in Northern Iran: Thalassemia Registry System
por: KOSARYAN, Mehrnoush, et al.
Publicado: (2019)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Amlodipine: Can act as an antioxidant in patients with transfusion‐dependent β‐thalassemia? A double‐blind, controlled, crossover trial
por: Darvishi‐Khezri, Hadi, et al.
Publicado: (2022)

Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2018)

Moderate to severe liver siderosis and raised AST are independent risk factors for vitamin D insufficiency in β-thalassemia patients
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2020)

Ferritin thresholds for cardiac and liver hemosiderosis in β-thalassemia patients: a diagnostic accuracy study
por: Darvishi-Khezri, Hadi, et al.
Publicado: (2022)

Ebselen: A promising therapy protecting cardiomyocytes from excess iron in iron-overloaded thalassemia patients
por: Ghazaiean, Mobin, et al.
Publicado: (2023)

The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension
por: Karami, Hossein, et al.
Publicado: (2018)

Extramedullary Hematopoiesis Presenting as a Right Adrenal Mass in a Patient With Beta Thalassemia
por: Karami, Hossein, et al.
Publicado: (2014)

Skin Protective Activity of Silymarin and its Flavonolignans
por: Vostálová, Jitka, et al.
Publicado: (2019)

Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota
por: Valentová, Kateřina, et al.
Publicado: (2020)

Zinc Supplementation in Adult Mechanically Ventilated Trauma Patients is Associated with Decreased Occurrence of Ventilator-associated Pneumonia: A Secondary Analysis of a Prospective, Observational Study
por: Hasanzadeh Kiabi, Farshad, et al.
Publicado: (2017)

Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin
por: Vrba, Jiří, et al.
Publicado: (2020)

Simple and Rapid HPLC Separation and Quantification of Flavonoid, Flavonolignans, and 2,3-Dehydroflavonolignans in Silymarin
por: Petrásková, Lucie, et al.
Publicado: (2020)

The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo
por: Pourová, Jana, et al.
Publicado: (2019)

Dose Effect of Milk Thistle (Silybum marianum) Seed Cakes on the Digestibility of Nutrients, Flavonolignans and the Individual Components of the Silymarin Complex in Horses
por: Dockalova, Hana, et al.
Publicado: (2021)

Preparation, Characterization and Evaluation of Flavonolignan Silymarin Effervescent Floating Matrix Tablets for Enhanced Oral Bioavailability
por: Ahmad, Sher, et al.
Publicado: (2023)

Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD
por: Xie, Ying, et al.
Publicado: (2017)

Allele-Specific Loop-Mediated Isothermal Amplification for the Detection of IVSII-I G>A Mutation On β-Globin Gene
por: Gill, Pooria, et al.
Publicado: (2019)

AS-LAMP: A New and Alternative Method for Genotyping
por: Gill, Pooria, et al.
Publicado: (2020)

In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea
por: MAHDAVI, Mohammad Reza, et al.
Publicado: (2017)

Results of Double Blind Placebo Controlled Trial to Assess the Effect of Vitamin B6 on Managing of Nausea and Vomiting In Pediatrics with Acute Gastroenteritis
por: Derakhshanfar, Hojjat, et al.
Publicado: (2013)

Fluorescent Detection of Methicillin Resistant Staphylococcus aureus by Loop-mediated Isothermal Amplification Assisted with Streptavidin-coated Quantum Dots
por: Aliasgharian, Aily, et al.
Publicado: (2022)

Preparation of Retinoyl-Flavonolignan Hybrids and Their Antioxidant Properties
por: Chambers, Christopher S., et al.
Publicado: (2019)

Selectively Halogenated Flavonolignans—Preparation and Antibacterial Activity
por: Hurtová, Martina, et al.
Publicado: (2022)

Flavonolignans As a Novel Class of Sodium Pump Inhibitors
por: Kubala, Martin, et al.
Publicado: (2016)

Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular Models
por: Bijak, Michal, et al.
Publicado: (2017)

Flavonolignans inhibit the arachidonic acid pathway in blood platelets
por: Bijak, Michal, et al.
Publicado: (2017)

Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia
por: Hagag, Adel A., et al.
Publicado: (2013)

Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia
por: Reisi, Nahid, et al.
Publicado: (2022)

Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties
por: Valentová, Kateřina, et al.
Publicado: (2018)

New Flavonolignan Glycosides from the Aerial Parts of Zizania latifolia
por: Lee, Seung-Su, et al.
Publicado: (2015)

Dual SMO/BRAF Inhibition by Flavonolignans from Silybum marianum †
por: Diukendjieva, Antonia, et al.
Publicado: (2020)

Free Radical Scavenging and Antioxidant Activities of Silymarin Components
por: Anthony, Kevin P., et al.
Publicado: (2013)

Modulation of Skin Inflammatory Response by Active Components of Silymarin
por: Juráňová, Jana, et al.
Publicado: (2018)

Unconventional application of the Mitsunobu reaction: Selective flavonolignan dehydration yielding hydnocarpins
por: Huang, Guozheng, et al.
Publicado: (2016)

Relationship between beta-globin gene carrier state and insulin resistance
por: Bahar, Adele, et al.
Publicado: (2012)

Inhibitory Effect of Flavonolignans on the P2Y12 Pathway in Blood Platelets
por: Bijak, Michal, et al.
Publicado: (2018)

In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jhra44piakfjsvf8okgkrfrjg6